Home › Blood Cancers › NCT04776941
Expressive Writing for the Management of Stress in Cancer Survivors
COVID-19: A Virtual Feasibility Study to Manage Stress
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * At least 18 years old * Have a diagnosis of cancer within the past 3 years * Are able to speak and read in English * Have access to a computer or smart phone with internet connection * All disease sites and all cancer stages are eligible for enrollment Exclusion Criteria: * Inability to provide informed consent * Non-English speakers will be excluded because this is a feasibility study that will enroll only a limited number of participants
About the study
This clinical trial evaluates the effect of expressive writing for the management of stress in cancer survivors. Cancer diagnosis and treatment are associated with increased stress in cancer survivors related to concerns about family, career, relationships, finances, side effects of treatment, and death. This stress can be further exacerbated by social upheavals such as the COVID-19 pandemic. For safety reasons, many patients are isolated with restricted access to in-person health care and reduced social interaction with family and friends. Together with the economic uncertainties that come with this pandemic, these factors are likely to increase cancer survivors' stress levels. Expressive writing may provide a medium through which cancer survivors confront stressors and find meaning in their experience. The goal of this trial is to learn more about the experiences of cancer survivors during stressful times.
What is being tested
- Behavioral Intervention (behavioral)
- Behavioral Intervention (behavioral)
- Behavioral Intervention (behavioral)
- Behavioral Intervention (behavioral)
- Quality-of-Life Assessment (other)
- Questionnaire Administration (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 414 · Started: Aug 7, 2020
Contact the study team
- Qian LU, MD,PHD · Phone: 713-745-8324
Official record on ClinicalTrials.gov — NCT04776941
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.